ArriVent BioPharma, Inc. Common Stock (AVBP)

ArriVent BioPharma, Inc. Common Stock (AVBP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $821M; returns 1 day +9.4%, 1 week +26.1%, 1 year +16.1%.

ArriVent BioPharma Inc. (AVBP) is a clinical-stage biopharmaceutical company intensely focused on developing and commercializing innovative therapeutics, primarily for patients with difficult-to-treat cancers, particularly lung cancer.

Groups AVBP belongs to

• Clinical Stage Biotech
• Oncology
• Healthcare
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Antibody-Drug Conjugates
• Clinical Stage
• Rare Diseases

AVBP financial model: income statement, cash flow and balance sheet